Integra LifeSciences Holdings Corporation Stock
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 12.75 USD | -0.62% |
|
+7.05% | +2.66% |
| 10-27 | UBS Adjusts Integra LifeSciences Price Target to $14 From $19, Maintains Neutral Rating | MT |
| 10-23 | Truist Adjusts Price Target on Integra LifeSciences to $13 From $15, Maintains Hold Rating | MT |
| Market Cap | 992M 888M 817M 740M 1.38B 94.19B 1.41B 9.75B 3.91B 49.55B 3.72B 3.64B 156B | P/E 2026 * |
26x | P/E 2027 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.8B 2.51B 2.31B 2.09B 3.91B 266B 3.98B 27.5B 11.04B 140B 10.51B 10.28B 441B | EV / Sales 2026 * |
1.7x | EV / Sales 2027 * | 1.37x |
| Free-Float |
72.33% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IART | Delayed | |
CBOE
| IART | Real-time | |
|
Tradegate
| IL3 | Real-time | |
|
Deutsche Boerse AG
| IL3 | Delayed | |
|
Börse Stuttgart
| IL3 | Delayed | |
|
Boerse Muenchen
| IL3 | Real-time | |
|
Berne S.E.
| IL3 | End-of-day quote |
Last Transcript: Integra LifeSciences Holdings Corporation
| 1 day | -0.62% | ||
| 1 week | +7.05% | ||
| 1 month | -20.76% | ||
| 3 months | -23.42% | ||
| 6 months | +16.44% | ||
| Current year | +2.66% |
| 1 week | 11.72 |  | 13 |
| 1 month | 11.57 | | 14.28 |
| Current year | 8.7 | | 20.49 |
| 1 year | 8.7 | | 20.49 |
| 3 years | 8.7 | | 45.42 |
| 5 years | 8.7 | | 73.96 |
| 10 years | 8.7 | | 77.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stuart Essig
CEO | Chief Executive Officer | 64 | 01/05/2026 |
Lea Knight
DFI | Director of Finance/CFO | 54 | 28/06/2023 |
Teshtar Elavia
CTO | Chief Tech/Sci/R&D Officer | - | 17/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Stuart Essig
CHM | Chairman | 64 | 03/01/2012 |
Keith Bradley
BRD | Director/Board Member | 81 | 01/01/1992 |
Christian Schade
BRD | Director/Board Member | 65 | 01/01/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Other | Executive/Senior Manager | 67,801 | 0.0871% | ||
| 17/09/26 | Other | Company Secretary | 26,838 | 0.0345% | ||
| 01/09/26 | Tax | Head of Human Resources | -1,455 | 0.0019% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | +7.05% | +6.16% | -65.40% | 992M | |
| +1.56% | +2.41% | -14.09% | +11.78% | 184B | |
| -0.59% | +1.18% | +6.44% | +36.26% | 118B | |
| -6.38% | -4.98% | -18.07% | +7.28% | 111B | |
| +0.76% | +6.11% | -41.42% | +5.76% | 94.58B | |
| +0.09% | -0.05% | -2.06% | +76.70% | 63.13B | |
| -5.48% | -5.11% | -1.45% | +61.88% | 55.66B | |
| -0.23% | -0.52% | +10.73% | -22.03% | 53.9B | |
| -4.30% | -1.64% | -12.44% | +39.42% | 43.42B | |
| +0.05% | +1.97% | +0.24% | -10.32% | 34.68B | |
| Average | -1.51% | +0.76% | -6.60% | +14.13% | 75.94B | |
| Weighted average by Cap. | -1.21% | +0.25% | -10.42% | +21.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.64B 1.47B 1.35B 1.23B 2.29B 156B 2.34B 16.15B 6.48B 82.12B 6.17B 6.04B 259B | 1.67B 1.5B 1.38B 1.25B 2.34B 159B 2.38B 16.45B 6.6B 83.65B 6.29B 6.15B 264B |
| Net income | 35.57M 31.86M 29.3M 26.55M 49.63M 3.38B 50.56M 349M 140M 1.78B 133M 131M 5.6B | 69.57M 62.31M 57.32M 51.93M 97.08M 6.61B 98.89M 684M 274M 3.48B 261M 256M 10.96B |
| Net Debt | 1.81B 1.62B 1.49B 1.35B 2.52B 172B 2.57B 17.76B 7.13B 90.27B 6.78B 6.64B 285B | 1.31B 1.17B 1.08B 975M 1.82B 124B 1.86B 12.83B 5.15B 65.22B 4.9B 4.8B 206B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $12.75 | -0.62% | 1,038,771 |
| 29/10/26 | $12.83 | +4.82% | 1,188,113 |
| 28/10/26 | $12.24 | +2.09% | 1,789,034 |
| 27/10/26 | $11.99 | -0.91% | 1,431,837 |
| 26/10/26 | $12.10 | +1.60% | 916,427 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IART Stock
Select your edition
All financial news and data tailored to specific country editions
